GH Research PLC Ordinary Shares (GHRS)
GH Research PLC is a clinical-stage biopharmaceutical company focused on developing innovative psychedelics and neuromodulators for mental health and neurological disorders. Headquarters in Ireland, the company specializes in the research and development of novel compounds aimed at addressing unmet medical needs related to psychiatric conditions.
Company News
GH Research announced presentation of long-term clinical data on GH001, a potential treatment for treatment-resistant depression, at the 38th Annual European College of Neuropsychopharmacology Congress in Amsterdam.
GH Research (GHRS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceede...